U.S. federal trademark · Serial No. 90711834
Pharmaceuticals for reducing side effects or improving efficacy for cancer and oncology patients; pharmaceuticals for the prevention, treatment or management of superoxide mediated conditions; biotechnological preparations for medical use for the treatment of oncological disorders and treatment-related side effects
Research and development in the pharmaceutical and biotechnology fields
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.